Please enter your Phone Number. Send Thanks! A link has been sent. Done TransAsia plane crash in Penghu, Taiwan kills 51, 7 hurt GSK warns on profits as weak lung drug sales hit By By Ben Hirschler 13 minutes ago 0 shares A British Airways airplane flies past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London By Ben Hirschler LONDON (Reuters) – GlaxoSmithKline cut its 2014 earnings outlook after sales fell by a worse-than-expected 13 percent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth. A run of weak quarters highlights the pressure on Chief Executive Andrew Witty, whose drive to reshape Britain’s biggest drugmaker has yet to deliver the hoped-for return to sustained revenue growth, following a lengthy period of patent expiries. EDT), the biggest daily fall since 2008.
For the original version including any supplementary images or video, visit http://news.yahoo.com/gsk-cuts-outlook-weak-lung-drug-sales-strong-112441365–finance.html